A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis.

Saved in:

Bibliographic Details
Title:	A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis.
Authors:	Pandey, Krishna¹ drkrishnapandey@yahoo.com, Pal, Biplab², Siddiqui, Niyamat Ali³, Lal, Chandra Shekhar⁴, Ali, Vahab⁵, Bimal, Sanjiva⁶, Kumar, Ashish⁷, Verma, Neena⁸, Rabi Das, Vidya Nand¹, Singh, Shubhankar Kumar⁵, Topno, Roshan Kamal⁹, Das, Pradeep⁷, Pandey, Krishna¹⁰ (AUTHOR), Das, Vidya Nand Rabi¹⁰ (AUTHOR)
Source:	Indian Journal of Dermatology, Venereology & Leprology. Jan/Feb2021, Vol. 87 Issue 1, p34-41. 8p.
Database:	Academic Search Ultimate

Description
ISSN:	03786323
DOI:	10.25259/IJDVL_410_19